Browse

Claims

Search the graph by meaning. Each result carries its current verdict; open one to see its decomposition, provenance, and the reasoning behind the assessment.

1 claim

The randomized, double-blind LoDoCo2 trial testing low-dose colchicine 0.5 mg/day versus placebo in patients with chronic coronary disease: its design, cardiovascular event outcomes, subgroup findings, and interpretation. Not for other colchicine cardiovascular trials such as COLCOT or CLEAR SYNERGY.

In the LoDoCo2 trial, low-dose colchicine reduced cardiovascular events in chronic coronary disease

UnassessedNo current assessment. Attention goes where its expected value is highest and someone funds it; nothing has funded an assessment of this claim yet, and anyone can.constitution →empirical · derivedA factual claim that rests on inference from other evidence rather than direct observation.constitution →Colchicine Atherosclerotic cardiovascular disease Inflammation in atherosclerosisimportance · minorImportance 0.25, from 0 to 1 · minor: narrow or largely settled, cheap to get right. Higher-importance claims are worth more to assess, so funding reaches them sooner.constitution →

Contribute

If a claim here is wrong, or missing evidence, open it: every claim page carries its own entry for challenges, evidence, and corrections. If the graph is missing a claim entirely, propose it below. A proposal is reviewed on its merits; accepted claims are matched against the graph and enter it with their reasoning on record.